MeCure Industries Plc has announced its audited full-year results for the period ended 31 December 2025, showcasing a significant increase in profitability and revenue. The company reported a pre-tax profit of N7.93 billion, marking a substantial 140.18% increase from the N3.30 billion recorded in 2024.

Profit after tax experienced a notable surge, growing by 177.5% year-over-year to reach N6.463 billion, which the company notes is the highest in three years and over 80% of the combined profit of the previous three years.

Revenue for the year saw considerable growth, rising to N77.69 billion, up by 68.80% from the N46.03 billion recorded in the previous year. This increase reflects a strong expansion across MeCure's pharmaceutical manufacturing and distribution operations during the reported period.

In light of this strong financial performance, the Board has recommended a dividend payout of N0.32 per ordinary share for the financial year ended 31 December 2025, pending shareholders’ approval. This proposed dividend marks an 113.33% increase compared to the N0.15 paid for the 2024 financial year.

The company attributes its impressive bottom-line growth to robust revenue expansion, which helped to offset elevated direct costs, operating expenses, and higher finance costs incurred during the year.

This stronger topline performance translated into a 79.30% rise in gross profit, reaching N26.51 billion, indicating improved cost absorption despite higher input costs. Operating profit nearly doubled to N16.43 billion, reflecting operating leverage as marketing and administrative costs grew at a slower pace relative to revenue.

Despite a higher finance burden, operating profit remained strong enough to cover finance costs approximately 2 times, an improvement from the 1.6 times recorded in 2024, showcasing stronger operating efficiency despite elevated leverage.

The balance sheet reflects growth, with total assets increasing by 49.45% to N81.96 billion. This growth was supported by higher property, plant and equipment, inventories, and trade receivables.

Overall, the company delivered strong operating growth, albeit with a more leveraged balance sheet profile.

MeCure Industries' stock began the year with a share price of N65.20 and closed last week at N75.85, representing a year-to-date gain of 16.30%. The stock delivered an exceptional 369% gain last year, following a 15% increase in 2024. The sustained rally indicates continued investor confidence in the company’s earnings growth trajectory.